Literature DB >> 9815844

Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.

J Herrada1, R B Iyer, E N Atkinson, N Sneige, A U Buzdar, G N Hortobagyi.   

Abstract

The purpose of this study was to correlate physical examination and sonographic and mammographic measurements of breast tumors and regional lymph nodes with pathological findings and to evaluate the effect of neoadjuvant chemotherapy on clinical Tumor-Node-Metastasis stage by noninvasive methods. This was a retrospective analysis of 100 patients with locally advanced breast cancer registered and treated in prospective trials of neoadjuvant chemotherapy. All patients received four cycles of a doxorubicin-containing regimen and had noninvasive evaluation of the primary tumor and regional lymph nodes before and after neoadjuvant chemotherapy by physical examination, sonography, and mammography and underwent breast surgery and axillary dissection within 5 weeks after completion of neoadjuvant chemotherapy. The correlations between clinical and pathological measurements were determined by Spearman rank correlation analysis. A proportional odds model was used to examine predictive values. Eighty-three patients had both a clinically detectable primary tumor and lymph node metastases. Sixty-four patients had a decrease in Tumor-Node-Metastasis stage after chemotherapy. For 54% of patients, there was concordance in clinical response between the primary tumor and lymph node compartment; for the rest, results were discordant. Physical examination correlated best with pathological findings in the measurement of the primary tumor (P = 0.0003), whereas sonography was the most accurate predictor of size for axillary lymph nodes (P = 0.0005). The combination of physical examination and mammography worked best for assessment of the primary tumor (P = 0.003), whereas combining physical examination with sonography gave optimal evaluation of regional lymph nodes (P = 0.0001). In conclusion, physical examination is the best noninvasive predictor of the real size of locally advanced primary breast cancer, whereas sonography correlates better with the real dimensions of axillary lymph nodes. The combination of physical examination with either mammography or sonography significantly improves the accuracy of noninvasive assessment of tumor dimensions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9815844

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  34 in total

Review 1.  Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations.

Authors:  Nanda C Krak; Otto S Hoekstra; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-22       Impact factor: 9.236

2.  Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy.

Authors:  H J Shin; H H Kim; J H Ahn; S-B Kim; K H Jung; G Gong; B H Son; S H Ahn
Journal:  Br J Radiol       Date:  2010-11-16       Impact factor: 3.039

3.  Dynamic contrast-enhanced MRI and sonography in patients receiving primary chemotherapy for breast cancer.

Authors:  Filippo Montemurro; Laura Martincich; Giovanni De Rosa; Stefano Cirillo; Vincenzo Marra; Nicoletta Biglia; Marco Gatti; Piero Sismondi; Massimo Aglietta; Daniele Regge
Journal:  Eur Radiol       Date:  2005-01-27       Impact factor: 5.315

4.  Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.

Authors:  Anees B Chagpar; Lavinia P Middleton; Aysegul A Sahin; Peter Dempsey; Aman U Buzdar; Attiqa N Mirza; Fredrick C Ames; Gildy V Babiera; Barry W Feig; Kelly K Hunt; Henry M Kuerer; Funda Meric-Bernstam; Merrick I Ross; S Eva Singletary
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

5.  Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer.

Authors:  Jason D Keune; Donna B Jeffe; Mario Schootman; Abigail Hoffman; William E Gillanders; Rebecca L Aft
Journal:  Am J Surg       Date:  2010-04       Impact factor: 2.565

6.  Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy.

Authors:  H-M Baek; J-H Chen; O Nalcioglu; M-Y Su
Journal:  Ann Oncol       Date:  2008-03-27       Impact factor: 32.976

7.  Lymphatic-targeted therapy following neoadjuvant chemotherapy: a promising strategy for lymph node-positive breast cancer treatment.

Authors:  Jianghao Chen; Qing Yao; Hui Wang; Bo Wang; Juliang Zhang; Ting Wang; Yonggang Lv; Zenghui Han; Ling Wang
Journal:  Med Oncol       Date:  2015-05-26       Impact factor: 3.064

8.  Tumor size of breast invasive ductal cancer measured with contrast-enhanced ultrasound predicts regional lymph node metastasis and N stage.

Authors:  Zhiyuan Wang; Qichang Zhou; Jun Liu; Shichu Tang; Xia Liang; Zhengyu Zhou; Ying He; Hui Peng; Yuanming Xiao
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 9.  Accuracy of axillary ultrasound in the diagnosis of nodal metastasis in invasive breast cancer: a review.

Authors:  Jonathan Cools-Lartigue; Sarkis Meterissian
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

10.  The use of molecular breast imaging to assess response in women undergoing neoadjuvant therapy for breast cancer: a pilot study.

Authors:  Dietlind L Wahner-Roedler; Judy C Boughey; Carrie B Hruska; Beiyun Chen; Deborah J Rhodes; Cindy L Tortorelli; Robert W Maxwell; Stephen S Cha; Michael K O'Connor
Journal:  Clin Nucl Med       Date:  2012-04       Impact factor: 7.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.